U.S. Seeks Balance On Drug Access In Trans Pacific Partnership IP Talks
This article was originally published in PharmAsia News
Executive Summary
The United States remains hopeful that a sharp debate on access and stricter intellectual property rules in the TPP talks can be concluded by the end of the year after talks in Indonesia failed to break an impasse.